Pharma start-up funding partnerships can provide more than finance
Pharma start-ups are expensive but a partnership approach can lend credibility and attract additional investors
Life Sciences and Stem special report looks at how the life sciences sector in Ireland has played a huge part in the fight against Covid-19 and advancing Ireland’s reputation not only as a global leader in manufacturing but also in research and development.
Pharma start-ups are expensive but a partnership approach can lend credibility and attract additional investors
The EU MDR, although aimed at improving safety and capability, places significant demands on the industry
Despite its regulatory challenges, artificial intelligence makes this an exciting time to be involved in the pharmaceutical industry
To maintain our strong position in the globally competitive medtech sector, Ireland must remain innovative
In R&D, Ireland punches above its weight internationally – it’s important that we continue to move up the value chain
Stable policy and the highest number of Stem graduates per capita in the EU are just two of the reasons for Ireland’s enviable life sciences success
Its proven track record means Ireland is well positioned to benefit from the next wave of pharma advances
Smart medical devices and AI enhancement and integration have the potential to revolutionise healthcare
With multinationals in need of skilled, knowledgeable staff, Stem growth will help keep Ireland competitive
The sector has prospered in from continuing life investment but there are areas that could benefit from further development
Public-private collaboration was critical in the response to Covid-19
Demand for the adoption of digital health has accelerated as a result of Covid-19
The Irish medtech sector employs 40,000 people but maintaining our global reputation will require action in a number of areas
Ireland has evolved into a highly cohesive research and innovation ecosystem
New EU rules requiring recertification of medical devices by May 2024 have prompted fears that patient access to medtech may be put at risk
Yhe continued success in R&D delivering new therapies and treatments will rely on the continued innovation and ingenuity of research conducted by academic institutions/academic partners across Ireland
Ireland’s pharmaceutical industry has seen a steady evolution to a fully integrated sector since it was first established in the 1950s
Irish firms played crucial roles in national and international response to Covid-19
Sector employing 50,000 in Ireland leans towards scientific and engineering roles
Agility is important to the sector and valued by professionals who want to progress
Why Ireland is an attractive home for the world’s life science companies
‘I was the first woman to win that award and all of a sudden I had a huge influx of women applying to work here’
How life sciences companies are leveraging artificial intelligence
The country’s medtech sector is growing and soon to be an international hub
Icon PLC mobilised its vaccine resources to address global threat posed by virus
‘There are days you witness how a patient’s life improved because of a new study drug’
Company awarded best clinical research organisation in 2020 for third time
BioPharmaChem Skillnet seeing companies invest in lifelong learning during pandemic
Pandemic is accelerating adoption of telemedicine and remote monitoring
Industry needs to attract curious minds from all walks of life, says plant manager
Decades-long relationships helped Oxygen Care respond quickly to Covid-19 pandemic
Crosswords & puzzles to keep you challenged and entertained
Full general election coverage including analysis and results for all 43 constituencies
How does a post-Brexit world shape the identity and relationship of these islands
Weddings, Births, Deaths and other family notices